General Information of Drug Transporter (DT)
DT ID DTD0421 Transporter Info
Gene Name SLC5A12
Transporter Name Sodium-coupled monocarboxylate transporter 2
Gene ID
159963
UniProt ID
Q1EHB4
Post-Translational Modification of This DT
Overview of SLC5A12 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A12 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

480

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC5A12 Asparagine 480 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A12 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

38

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A12 Serine 38 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC5A12 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

491

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A12 Serine 491 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC5A12 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

584

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A12 Serine 584 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC5A12 [2] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

594

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A12 Serine 594 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC5A12 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

607

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A12 Serine 607 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A12 [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

246

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A12 Threonine 246 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC5A12 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

248

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A12 Threonine 248 has the potential to affect its expression or activity.

  Tyrosine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A12 [2]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

601

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A12 Tyrosine 601 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC5A12 [2]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

608

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A12 Tyrosine 608 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: SC5AC_HUMAN)
2 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
3 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
4 A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
5 Fully automatic separation and identification of phosphopeptides by continuous pH-gradient anion exchange online coupled with reversed-phase liquid chromatography mass spectrometry. J Proteome Res. 2009 Jan;8(1):133-41.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.